Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 8,694 | 9,870 | 11,436 | 9,251 | 9,040 |
| Operating Income | -8,694 | -9,870 | -11,436 | -9,251 | -9,040 |
| Other Income | 203 | 281 | 499 | 559 | 617 |
| Pre-tax Income | -8,491 | -9,589 | -10,937 | -8,692 | -8,423 |
| Net Income Continuous | -8,491 | -9,589 | -10,937 | -8,692 | -8,423 |
| Net Income | $-8,491 | $-9,589 | $-10,937 | $-8,692 | $-8,423 |
| EPS Basic Total Ops | -0.95 | -1.11 | -1.23 | -1.05 | -0.98 |
| EPS Basic Continuous Ops | -0.95 | -1.11 | -1.27 | -1.01 | -0.98 |
| EPS Diluted Total Ops | -0.95 | -1.11 | -1.23 | -1.05 | -0.98 |
| EPS Diluted Continuous Ops | -0.95 | -1.11 | -1.27 | -1.01 | -0.98 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.11 | N/A | -1.05 | -1.05 |
| EBITDA(a) | $-8,690 | $-9,866 | $-11,432 | $-9,247 | $-9,036 |